廣告
香港股市 將在 2 小時 52 分鐘 開市

  • 恒指

    18,578.30
    +102.38 (+0.55%)
     

  • 國指

    6,572.45
    +25.16 (+0.38%)
     

  • 上證綜指

    3,140.72
    +35.90 (+1.16%)
     

  • 道指

    38,852.27
    +176.59 (+0.46%)
     

  • 標普 500

    5,180.74
    +52.95 (+1.03%)
     

  • 納指

    16,349.25
    +192.92 (+1.19%)
     

  • Vix指數

    13.49
    0.00 (0.00%)
     

  • 富時100

    8,213.49
    +41.34 (+0.51%)
     

  • 紐約期油

    78.84
    +0.36 (+0.46%)
     

  • 金價

    2,333.90
    +2.70 (+0.12%)
     

  • 美元

    7.8176
    +0.0073 (+0.09%)
     

  • 人民幣

    0.9215
    -0.0049 (-0.53%)
     

  • 日圓

    0.0505
    -0.0003 (-0.55%)
     

  • 歐元

    8.4183
    +0.0120 (+0.14%)
     

  • Bitcoin

    63,500.90
    -246.08 (-0.39%)
     

  • CMC Crypto 200

    1,367.57
    +54.95 (+4.19%)
     

23andMe CEO Wojcicki considering taking firm private, filing shows

Reuters
·1 分鐘文章

(Reuters) - 23andMe co-founder and chief executive Anne Wojcicki is considering making an offer to buy the genetics testing company in a potential go-private transaction, a regulatory filing on late Wednesday showed.

Last week, Wojcicki notified members of the board's special committee that she is considering a potential go-private transaction for 23andMe and indicated that she would begin speaking to partners and financing sources.

23andMe declined to comment on the filing and Wojcicki did not immediately respond to a Reuters' request for comment.

Last year, the company informed several customers of a data breach in the "DNA Relatives" feature that allowed them to compare ancestry information with users worldwide.

廣告

23andMe, best known for its saliva-based test kits that offer users a glimpse into their genetic ancestry went public in 2021 through a blank-check firm, backed by Virgin Group founder Richard Branson, in a deal that valued the merged entity at $3.5 billion.

(Reporting by Mrinmay Dey in Bengaluru; Editing by Eileen Soreng)